Skip to main content
. Author manuscript; available in PMC: 2021 Jan 27.
Published in final edited form as: Immunohorizons. 2020 Aug 4;4(8):444–453. doi: 10.4049/immunohorizons.2000068

Figure 2.

Figure 2.

Definition of ZIKV peptides recognized by polyclonal ZIKV-reactive CD4 T cell lines enriched from ZIKV-seropositive donors. At left, the AIM-enriched bulk T cells from donor 24 were queried with pooled proteome-covering ZIKV-peptides using autologous EBV-LCL as APC. At right, single peptides within pool 17 were tested. Assays are triplicate’; stdev= standard deviation of the mean.